1673-7806
2016 Issue 5
..............page:353-356
Protective Effect of Curcumin on Liver Injury Induced by Triptolide
ZHANG Wei-xia;,LI Juan;,CHEN He-feng;,CHEN Bing;
ZHANG Wei-xia;,LI Juan;,CHEN He-feng;,CHEN Bing;
..............page:357-360
Identification of Plasma miRNA-21 as a Biomarker for Diagnosis and Chemotherapy Prognosis in Non-Small Cell Lung Cancer
WEI Juan;,GAO Wen;,SHU Yong-qian;
WEI Juan;,GAO Wen;,SHU Yong-qian;
..............page:361-364
Pachymaran Extraction by Response Surface Methodology
YAN Ming;,WEI Ying-chun;,YANG Jing;,XU Dian-hong;,WANG Zhen-zhong;,XIAO Wei;
YAN Ming;,WEI Ying-chun;,YANG Jing;,XU Dian-hong;,WANG Zhen-zhong;,XIAO Wei;
..............page:365-367
Exploration of Quality Control and Clinical Application of 99mTc-Tetrofos-min Injections Prepared in Hospital
CHEN Zhi-ming;,WANG Yang;,HE Yong-jun;,YE Wan-zhong;,FAN Yi-jun;,HUANG Xu-quan;
CHEN Zhi-ming;,WANG Yang;,HE Yong-jun;,YE Wan-zhong;,FAN Yi-jun;,HUANG Xu-quan;
..............page:368-370
Immune Turbidimetry My5-FUTM Method for Monitoring Plasma Concen-tration of 5-FU in Gastric Cancer Patients Given S-1
GUO Zheng-dong;,ZHOU Zhao-fei;,ZHOU Yun;,SHEN Bo;,JI Xiao-zhi;,ZHANG Yun-bin;,LI Qian-long;,LU Jian-wei;
GUO Zheng-dong;,ZHOU Zhao-fei;,ZHOU Yun;,SHEN Bo;,JI Xiao-zhi;,ZHANG Yun-bin;,LI Qian-long;,LU Jian-wei;
..............page:371-374
A Validated HPLC-MS/MS Method for the Determination of Sitafloxacin in Human Urine
BIAN Min-liang;,SUN Lu-ning;,FANG Yun-qian;,ZHANG Hong-wen;,LI Yue-qi;,JIAO Hui-wen;,YUANZI Qing-yun;,YU Li-yuan;,WANG Yong-qing;
BIAN Min-liang;,SUN Lu-ning;,FANG Yun-qian;,ZHANG Hong-wen;,LI Yue-qi;,JIAO Hui-wen;,YUANZI Qing-yun;,YU Li-yuan;,WANG Yong-qing;
..............page:375-377
Separation of Enantiomers of Calcium Folinate by HPLC with Chiral Mo-bile Phase Additives
ZHAN Shao-qing;,WANG Xiao-feng;
ZHAN Shao-qing;,WANG Xiao-feng;
..............page:378-380
Revision of Quality Standards of Artemisia anomala
GE Jian-hua;,HU Hao-bin;,GONG Xu-dong;,XU Hu;,XU Dan-yang;
GE Jian-hua;,HU Hao-bin;,GONG Xu-dong;,XU Hu;,XU Dan-yang;
..............page:381-382
HPLC Determination of Ribavirin in the Virazole Creams
CHENG Ji-ye;,LIU Hua-ming;,TIAN Pei-lin;,JIN Wei-bin;
CHENG Ji-ye;,LIU Hua-ming;,TIAN Pei-lin;,JIN Wei-bin;
..............page:383-384
Improved Synthesis of Vortioxetine Hydrobromide
WANG Xin;,ZHAO Wei;,SU Peng;,GAO Rui;,WANG De-cai;
WANG Xin;,ZHAO Wei;,SU Peng;,GAO Rui;,WANG De-cai;
..............page:385-386
Stability of Dex-lansoprazole Injections and Lansoprazole Injections in the Normal Saline Solutions
FANG Yun-qian;,SUN Lu-ning;,LI Yue-qi;,YANG Zhi-cheng;,GONG Xiao-jian;,WANG Yong-qing;
FANG Yun-qian;,SUN Lu-ning;,LI Yue-qi;,YANG Zhi-cheng;,GONG Xiao-jian;,WANG Yong-qing;
..............page:387-389
Consistency of Dissolubility of Trimetazidine Dihydrochloride Tablets Be-tween Generic and Original Preparations
DAI Zhun;,SONG Jin-chun;,SUN Zhi-cheng;
DAI Zhun;,SONG Jin-chun;,SUN Zhi-cheng;
..............page:390-392
Optimizing the Preparation of Oxiracetam for Injection by Orthogonal Design
HAN Wang;,WEI Lei;
HAN Wang;,WEI Lei;
..............page:393-394
Pharmacological and Clinical Studies of Vonoprazan Fumarate
LU Hui;,CHEN Xiang-feng;
LU Hui;,CHEN Xiang-feng;
..............page:395-398
Use of ADE Trigger Tool for Monitoring Adverse Drug Events
ZHANG Hai-xia;,FENG Jia-xing;,LIU Jin-chun;,GE Wei-hong;
ZHANG Hai-xia;,FENG Jia-xing;,LIU Jin-chun;,GE Wei-hong;
..............page:399-403
Two Cases of Yuan Hu Caused Liver Injury
LI Yan-hua;,ZHAI Li-jie;,XIAO Fang;,CAI Hang;,JIANG Yi;
LI Yan-hua;,ZHAI Li-jie;,XIAO Fang;,CAI Hang;,JIANG Yi;
..............page:404-406
Establishment and Validation of the Reasonable Application Evaluation Model of Human Serum Albumin
HUANG Min-yan;,CHEN Xia;
HUANG Min-yan;,CHEN Xia;
..............page:407-408
Discussion on the Working Mode of Pharmacists Participating in the Man-agement of Clinical Rational Use of Albumin
LI Li;,BIAN Xiao-jie;,QIU Yu-dong;,GE Wei-hong;,ZOU Meng;,YANG Ming-xin;,DING Yan-zhi;
LI Li;,BIAN Xiao-jie;,QIU Yu-dong;,GE Wei-hong;,ZOU Meng;,YANG Ming-xin;,DING Yan-zhi;
..............page:409-412
Effects of Pharmaceutical Care for Non-small Cell Lung Cancer with Clinical Pharmacists Involved
ZHOU Dan-li;,WANG Jian;,ZHANG Jin-ping;
ZHOU Dan-li;,WANG Jian;,ZHANG Jin-ping;
..............page:413-416
Investigation on the Rationality of Lansoprazole for Injection in Inpatients
WEI Rong;,GU Hai-juan;,XU Yan-yan;,GUO Xiao-hong;,MEI Dan;,YANG Yang;,ZHU Dong-mei;
WEI Rong;,GU Hai-juan;,XU Yan-yan;,GUO Xiao-hong;,MEI Dan;,YANG Yang;,ZHU Dong-mei;
..............page:417-418
tou zuo zuo zuo zhi yan zhong guo min fan ying ban rong xue xing pin xue 1 li fen xi
liu xin zuo ;, mu xin wei ;, zhu jun rong ;
liu xin zuo ;, mu xin wei ;, zhu jun rong ;
..............page:419-420
Cause Analysis and Discussion of an Anaphylactic Shock Case with Carbo-prost Tromethamine
CHEN Yan;,SONG Hui-zhu;,CHEN Ming-zhu;,WEN Hao;,LU Ying-rong;,LIU Hai-ping;
CHEN Yan;,SONG Hui-zhu;,CHEN Ming-zhu;,WEN Hao;,LU Ying-rong;,LIU Hai-ping;
..............page:421-422
Analysis of Two Cases of Adverse Drug Events Induced by Errors in High-alert Medications
SI Ji-gang;
SI Ji-gang;
..............page:423-424
Common Problems and Countermeasures for the Bioequivalence Trial Data Verification
ZHU Yu-xian;,ZHANG Jun;,XIONG Ning-ning;,JIANG Meng;,JU Wen-zheng;,ZOU Chong;,YIN Jun-gang;,LIU Fang;
ZHU Yu-xian;,ZHANG Jun;,XIONG Ning-ning;,JIANG Meng;,JU Wen-zheng;,ZOU Chong;,YIN Jun-gang;,LIU Fang;
..............page:425-428
European Drug Marketing Authorization System and Enlightenment to China
ZHAO Na;,HU Xiao-shu;
ZHAO Na;,HU Xiao-shu;
..............page:429-432